logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Dendreon Priced To Go Out of Business

  +Follow August 23, 2013 4:12PM
Share:
Tickers Mentioned:

An analyst at Deutsche Bank downgraded Dendreon Corp. (DNDN) on Aug. 23, lowering the price target on the biotech company all the way to $1 a share. The bank noted that Dendreon has posted disappointing sales of their prostate cancer treatment drug Sipuleucel-T  (trade name Provenge) and is accumulating massive debt, and is in trouble of going under completely.

Duetsche's assessment of the Seattle, Wa.-based biotech was dire. In a note to investors, analyst Robyn Karnauskas wrote, “Per our calculations, even if there is drastic restructuring and significant cost cuts, spending may still outpace [revenue] growth in the near term. Consequentially, we believe that the terms of a debt refinancing may have a negative impact on equity holders.” The company downgraded Dendreon to “sell.” Deutsche had previously held a $6 price target for the stock.

Following Dendreon’s dismal second quarter earnings on Aug. 17, Wedbush Securities analyst David Nierengarten was even more pessimistic than Deutsche, and put his price target of the company at zero. That is, the only option for the troubled company is to file for bankruptcy.

Nierengarten said the company’s flagship product Provenge has always been doomed, as it is too expensive to produce and turn a profit, and thus Dendreon stands no chance of survival.

Dendreon was priced as high as $57.67 a share in April 2010 following the FDA approval of Provenge, and the stock hovered between $30 and $40 until Aug. 4, 2011. On that date the company abandoned its forecast for Provenge, and the stock fell 66 percent that day, and has continued plummeting since.

Dendreon dropped 9.72 percent on the poor analyst forecast to hit $2.88 a share, the lowest the stock has been in over four years.

(image courtesy of Flickr)

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Signup for our daily newsletter and get our best articles emailed right to you!

Results for dndn
PennyStocker
30 Mar 15 16:39:17
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
PennyStocker
30 Mar 15 12:45:14
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
PennyStocker
30 Mar 15 06:38:06
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
shmittahcapital
30 Mar 15 05:41:04
@sprt234a: Mitch gold hS a new company $dndn
PennyStocker
29 Mar 15 12:32:17
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
Quantuck Geske
29 Mar 15 03:32:49
$DNDN major bounce coming in the next days!
PennyStocker
28 Mar 15 11:22:11
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
Placidia Wehrheim
28 Mar 15 08:47:09
$DNDN major bounce coming in the next days!
Brookmont Nelda
28 Mar 15 00:06:58
$DNDN major bounce coming in the next days!
Adam Feuerstein
27 Mar 15 13:08:01
What was $DNDN thinking? Should have applied Jean-Francois Mouney Rule: If we exclude our crushing debt, we're solvent!"
equities.com
27 Mar 15 10:13:12
3 Biotech Stocks with the Potential to Become Major Game-Changers $args $VRX:CA $VRX $dndn $RHHBY $ino $SGMO $NVO http://t.co/IQJP0O5knC
PennyStocker
27 Mar 15 08:21:45
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
PennyStocker
26 Mar 15 12:58:02
Wow the last pick from http://t.co/p3LC54ps4x popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
WeedX
26 Mar 15 11:54:03
RT @dhovekamp42: @EPClinicalTrial @EPVantage Sorry. but $MDG DC is $DNDN DC - it is comparing a Tesla with a Truck - both start with T http…
Dieter Hovekamp
26 Mar 15 11:48:21
@EPClinicalTrial @EPVantage Sorry. but $MDG DC is $DNDN DC - it is comparing a Tesla with a Truck - both start with T http://t.co/RVsrHpleNm
Hallbrook
26 Mar 15 10:24:06
$DNDN major bounce coming in the next days!
PennyStocker
25 Mar 15 16:28:49
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
E B
25 Mar 15 13:05:58
.@megtirrell @bradloncar @CNBCFastMoney @Forbes wasn't he the CEO for $DNDN too?
PennyStocker
25 Mar 15 12:20:27
Wow the last pick from http://t.co/p3LC54H2W5 popped over 450%. Nice for being free. $AUY $S $KGC $DNDN
$Stocknewsalerts
25 Mar 15 03:46:05
$DNDN New SEC Document(s) for Dendreon Corporation From our Stock News Alerts App
Penny Stock Secret
25 Mar 15 00:06:03
Yesterday We Made $94,000 In Just One Trade More Info Here http://t.co/NovWYeksZ7 .. $DNDN $NAII $VOXX
Canoe Bay
24 Mar 15 18:22:25
$AMBS is down 40% recently. About the time since CEO became Twitter friends with AF. Coincidence? $PPHM $AMRN $DNDN #biodrama
				
				
  +Follow August 23, 2013 4:12PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.